Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2019-09-20 2019-09-20
Drug Identification Number 02423383 02423383
Brand name APO-SOLIFENACIN APO-SOLIFENACIN
Common or Proper name SOLIFENACIN SOLIFENACIN
Company Name APOTEX INC APOTEX INC
Ingredients SOLIFENACIN SUCCINATE SOLIFENACIN SUCCINATE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 BTL and 100BTL 30 BTL and 100BTL
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-08-30 2019-08-30
Actual discontinuation date 2019-09-19 2019-09-20
Remaining supply date 2019-08-30 2019-08-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments